Breaking News

You are here » Indian-Commodity  :  Commodities  :  Gold Gets Back On Discount Hunting, Greenback Drop

13-May2011

Gold Gets Back On Discount Hunting, Greenback Drop

Yellow metal rates rebounded in the period right after hitting intraday lower levels and completed with reasonable increases on Thursday, as traders turned to base fishing after American dollar corrected their earlier benefits. Issues over worldwide financial rescue too helped the gold rates as trader predicted that China`s continual plan activities to control in inflation could create a downturn in worldwide growth leads.

Gold commodity for June supply obtained $5.40 to stay at $1,506.80 an oz after dealing as higher as $1,506.50 and as lower as $1,477.60 on the Comex section of NYME , while the spot yellow metal rates increased $6 to stay at $1,506.90 an oz.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......